1. Jbara, Amina, Lin, Kuan-Ting, Stossel, Chani, Golan, Talia, Karni, Rotem. 2023. RBFOX2 modulates a metastatic signature of alternative splicing in pancreatic cancer. In Nature, 617, 147-153. doi:10.1038/s41586-023-05820-3. https://pubmed.ncbi.nlm.nih.gov/36949200/
2. Dou, Xiaoyang, Xiao, Yu, Shen, Chao, Chen, Jianjun, He, Chuan. 2023. RBFOX2 recognizes N6-methyladenosine to suppress transcription and block myeloid leukaemia differentiation. In Nature cell biology, 25, 1359-1368. doi:10.1038/s41556-023-01213-w. https://pubmed.ncbi.nlm.nih.gov/37640841/
3. Li, Shangbiao, Chen, Yanwen, Xie, Yuxin, Deng, Fan, Zhou, Aidong. 2023. FBXO7 Confers Mesenchymal Properties and Chemoresistance in Glioblastoma by Controlling Rbfox2-Mediated Alternative Splicing. In Advanced science (Weinheim, Baden-Wurttemberg, Germany), 10, e2303561. doi:10.1002/advs.202303561. https://pubmed.ncbi.nlm.nih.gov/37822160/
4. Li, Pengpeng, Qin, Dongxia, Chen, Tiange, Sun, Yu, Wang, Juejin. 2023. Dysregulated Rbfox2 produces aberrant splicing of CaV1.2 calcium channel in diabetes-induced cardiac hypertrophy. In Cardiovascular diabetology, 22, 168. doi:10.1186/s12933-023-01894-5. https://pubmed.ncbi.nlm.nih.gov/37415128/
5. Shi, De-Li. 2024. RNA-Binding Proteins in Cardiomyopathies. In Journal of cardiovascular development and disease, 11, . doi:10.3390/jcdd11030088. https://pubmed.ncbi.nlm.nih.gov/38535111/
6. Arya, Anurada D, Wilson, David I, Baralle, Diana, Raponi, Michaela. . RBFOX2 protein domains and cellular activities. In Biochemical Society transactions, 42, 1180-3. doi:10.1042/BST20140050. https://pubmed.ncbi.nlm.nih.gov/25110022/
7. Bareche, Y, Kelly, D, Abbas-Aghababazadeh, F, Haibe-Kains, B, Stagg, J. 2022. Leveraging big data of immune checkpoint blockade response identifies novel potential targets. In Annals of oncology : official journal of the European Society for Medical Oncology, 33, 1304-1317. doi:10.1016/j.annonc.2022.08.084. https://pubmed.ncbi.nlm.nih.gov/36055464/
智鼠故事 
